OPK Opko Health Inc

Price (delayed)

$2.59

Market cap

$1.77B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$1.93B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and ...

Highlights
The debt has increased by 10% QoQ but it has decreased by 4.9% YoY
Opko Health's EPS has plunged by 200% YoY
The net income has dropped by 197% year-on-year

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
681.53M
Market cap
$1.77B
Enterprise value
$1.93B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.09
Price to sales (P/S)
1.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Earnings
Revenue
$1.56B
EBIT
-$106.84M
EBITDA
-$20.3M
Free cash flow
$30.6M
Per share
EPS
-$0.19
Free cash flow per share
$0.05
Book value per share
$2.37
Revenue per share
$2.36
TBVPS
$1.36
Balance sheet
Total assets
$2.31B
Total liabilities
$691.97M
Debt
$271.22M
Equity
$1.61B
Working capital
$444.9M
Liquidity
Debt to equity
0.17
Current ratio
2.44
Quick ratio
1.02
Net debt/EBITDA
-8.32
Margins
EBITDA margin
-1.3%
Gross margin
31.1%
Net margin
-7.5%
Operating margin
-5.9%
Efficiency
Return on assets
-4.9%
Return on equity
-6.9%
Return on invested capital
-9.7%
Return on capital employed
-5.3%
Return on sales
-6.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
0.78%
1 week
4.02%
1 month
-19.06%
1 year
-36.52%
YTD
-46.15%
QTD
-24.71%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$1.56B
Gross profit
$485.21M
Operating income
-$92.11M
Net income
-$116.65M
Gross margin
31.1%
Net margin
-7.5%
The net income has dropped by 197% year-on-year
OPK's operating margin has dropped by 177% year-on-year
The operating income has plunged by 167% YoY
The gross profit has contracted by 26% YoY and by 17% from the previous quarter

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
1.09
P/S
1.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Opko Health's EPS has plunged by 200% YoY
The P/B is 33% below the last 4 quarters average of 1.6 and 17% below the 5-year quarterly average of 1.3
Opko Health's equity has decreased by 4.8% YoY and by 4.2% QoQ
The P/S is 43% below the 5-year quarterly average of 1.9 and 27% below the last 4 quarters average of 1.5
The company's revenue fell by 12% QoQ and by 12% YoY

Efficiency

How efficient is Opko Health business performance
The ROA has plunged by 198% YoY
The ROE has shrunk by 195% YoY
Opko Health's ROS has plunged by 177% YoY
OPK's ROIC has dropped by 169% year-on-year

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
Opko Health's current ratio has soared by 65% YoY but it has decreased by 2% from the previous quarter
OPK's total liabilities is down by 16% year-on-year and by 3.2% since the previous quarter
The debt is 83% lower than the equity
The debt to equity is up by 13% since the previous quarter
The debt has increased by 10% QoQ but it has decreased by 4.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.